Mediators of Inflammation

Immunometabolism: Molecular Mechanisms, Diseases, and Therapies 2016


Publishing date
21 Oct 2016
Status
Published
Submission deadline
03 Jun 2016

Lead Editor

1University of Sao Paulo, Sao Paulo, Brazil

2Sao Paulo State University, Presidente Prudente, Brazil

3National Institute of Health, Bethesda, USA

4National Institute of Health, Bethesda, USA


Immunometabolism: Molecular Mechanisms, Diseases, and Therapies 2016

Description

Chronic nonresolving inflammation is a critical condition found in several highly incident diseases such as obesity, cancer, type 2 diabetes, and atherosclerosis. Despite major implication in disease, the mechanisms underlying the development and failure to resolve such chronic inflammation are still not completely elucidated. Several lines of evidence indicate the existence of a complex interrelationship between inflammatory processes and metabolism. In this sense, changes in metabolism as those found upon overnutrition among other situations were demonstrated to modulate leukocyte function and induce inflammatory processes. Indeed, changes in the activity of the nutrient sensors mTOR and PPARs, for example, are associated with important alterations in inflammatory processes. Conversely, inflammation and inflammatory mediators are associated with major changes in cell and tissue metabolism. For instance, chronic inflammation is associated with an impairment of insulin stimulating glucose uptake and inhibition of lipolysis, in addition to the cross talk between metabolic organs, such as liver, adipose tissue, skeletal muscle, and gastrointestinal tract with immune cells.

In this special issue, we invite investigators to contribute original research and review articles that address the complex interrelationships between immune system and metabolism. We are particularly interested in articles describing novel mechanisms of interaction between nutrients and metabolites, immune function and inflammation, and possible strategies to prevent or treat metabolic diseases.

Potential topics include, but are not limited to:

  • Cell nutrient and energy sensors (G protein-coupled receptors, mTOR, PPARs, AMPK, etc.) as regulators of leukocyte function, immune responses, and inflammation
  • Microbiome and therapies associated with pre- and probiotics in metabolic diseases
  • Modulation of lipid, protein, and carbohydrate metabolism by inflammatory mediators
  • Metabolomics and lipidomics of cells and tissue upon inflammatory conditions

Articles

  • Special Issue
  • - Volume 2016
  • - Article ID 1759027
  • - Research Article

Conjugated Bilirubin Differentially Regulates CD4+ T Effector Cells and T Regulatory Cell Function through Outside-In and Inside-Out Mechanisms: The Effects of HAV Cell Surface Receptor and Intracellular Signaling

Karla F. Corral-Jara | Jorge L. Trujillo-Ochoa | ... | Nora A. Fierro
  • Special Issue
  • - Volume 2016
  • - Article ID 1638916
  • - Research Article

Negative Impact of Hypoxia on Tryptophan 2,3-Dioxygenase Function

Frank Elbers | Claudia Woite | ... | Silvia K. Eller
  • Special Issue
  • - Volume 2016
  • - Article ID 4121837
  • - Review Article

Inflammation Thread Runs across Medical Laboratory Specialities

Urs Nydegger | Thomas Lung | ... | Thomas Bodmer
  • Special Issue
  • - Volume 2016
  • - Article ID 8071539
  • - Review Article

Sickness-Associated Anorexia: Mother Nature’s Idea of Immunonutrition?

Gustav van Niekerk | Ashwin W. Isaacs | ... | Anna-Mart Engelbrecht
  • Special Issue
  • - Volume 2016
  • - Article ID 3085390
  • - Research Article

Inverse Relationship of the CMKLR1 Relative Expression and Chemerin Serum Levels in Obesity with Dysmetabolic Phenotype and Insulin Resistance

Fernanda-Isadora Corona-Meraz | Rosa-Elena Navarro-Hernández | ... | Mónica Vázquez-Del Mercado
  • Special Issue
  • - Volume 2016
  • - Article ID 7015620
  • - Research Article

Correlation of A2bAR and KLF4/KLF15 with Obesity-Dyslipidemia Induced Inflammation in Uygur Population

Cuizhe Wang | Xiaodan Ha | ... | Jun Zhang
Mediators of Inflammation
 Journal metrics
See full report
Acceptance rate14%
Submission to final decision136 days
Acceptance to publication27 days
CiteScore7.700
Journal Citation Indicator0.570
Impact Factor4.6
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.